Non-Current Assets
Total Assets
Alnylam Pharmaceuticals Total Assets increased by 3.3% to $5.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.7%, from $4.21B to $5.13B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 7.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Growth in total assets typically mirrors the overall expansion of the business, provided it is accompanied by corresponding revenue growth.
Detailed definition
The aggregate value of everything the company owns, including both short-term liquid resources and long-term physical an...
Peer comparison
Used to compare the scale of operations across the industry; larger asset bases generally suggest a more dominant market presence.
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.51B | $3.47B | $3.64B | $3.43B | $3.33B | $3.54B | $3.55B | $3.39B | $3.40B | $3.84B | $3.83B | $3.82B | $4.01B | $4.21B | $4.24B | $4.21B | $4.57B | $4.85B | $4.97B | $5.13B |
| QoQ Change | — | -1.1% | +4.9% | -5.8% | -3.0% | +6.2% | +0.3% | -4.4% | +0.3% | +12.8% | -0.2% | -0.1% | +4.8% | +4.9% | +0.8% | -0.6% | +8.4% | +6.3% | +2.4% | +3.3% |
| YoY Change | — | — | — | — | -5.1% | +1.8% | -2.7% | -1.2% | +2.2% | +8.6% | +8.0% | +12.7% | +17.8% | +9.5% | +10.7% | +10.2% | +13.9% | +15.4% | +17.1% | +21.7% |
Range$3.33B – $5.13B
CAGR+8.3%
Avg YoY Growth+8.8%
Median YoY Growth+9.9%
Current Streak4 quarters growth
Total Assets at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's total assets?
- Alnylam Pharmaceuticals (ALNY) reported total assets of $5.13B in Q1 2026.
- How has Alnylam Pharmaceuticals's total assets changed year-over-year?
- Alnylam Pharmaceuticals's total assets increased by 21.7% year-over-year, from $4.21B to $5.13B.
- What is the long-term trend for Alnylam Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's total assets has grown at a 7.8% compound annual growth rate (CAGR), from $3.41B to $4.97B.
- What does total assets mean?
- The total value of everything the company owns, from cash to buildings.